Contract facts
NONENo full NAICS 611310 intel page yet. Browse NAICS intelligence
STIMULANT DRUG TESTING is a federal NONE award for Headquaters held by University of Arkansas for Medical Sciences. Estimated value $102K ($102K obligated). Current period of performance ends Aug 31, 2027. Last award drew 1 bidder. Place of performance: LITTLE ROCK AR.
Recompete timing
PublicCurrent PoP ends Aug 31, 2027 (375 days remaining). Agencies typically plan 12–18 months ahead — position before the PoP clock runs out.
Incumbent footprint
Public recordUniversity of Arkansas for Medical Sciences — $3.3M obligated across 38 awards (firm-wide, all agencies) · lead buyer Department of Veterans Affairs (VA).
Related awards
Same parent · incumbentQuery this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract 15DDHQ26F00000704?
15DDHQ26F00000704 (Stimulant DRUG testing) is a Headquaters award with a potential value of $102K, currently held by University of Arkansas for Medical Sciences. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
Which office awarded 15DDHQ26F00000704?
Headquaters awarded 15DDHQ26F00000704 to University of Arkansas for Medical Sciences (potential $102K).
Who is the incumbent on 15DDHQ26F00000704?
University of Arkansas for Medical Sciences is the incumbent with $3.3M across 38 related awards in SCOUT’s public footprint. The current period of performance ends Aug 31, 2027.
When does University of Arkansas for Medical Sciences’s 15DDHQ26F00000704 come up for recompete?
SCOUT tracks a period-of-performance end of Aug 31, 2027. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.